These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2875702)

  • 1. Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome. Prediction of recovery and relapse in treatment with antidepressants and neuroleptics.
    Langer G; Koinig G; Hatzinger R; Schönbeck G; Resch F; Aschauer H; Keshavan MS; Sieghart W
    Arch Gen Psychiatry; 1986 Sep; 43(9):861-8. PubMed ID: 2875702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs.
    Langer G; Resch F; Aschauer H; Keshavan MS; Koinig G; Schönbeck G; Dittrich R
    Neuropsychobiology; 1984; 11(4):213-8. PubMed ID: 6436728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH response to TRH and haloperidol response latency in psychoses.
    Beasley CM; Magnusson M; Garver DL
    Biol Psychiatry; 1988 Aug; 24(4):423-31. PubMed ID: 3136807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRH test and DST in schizoaffective mania, mania, and schizophrenia.
    Kiriike N; Izumiya Y; Nishiwaki S; Maeda Y; Nagata T; Kawakita Y
    Biol Psychiatry; 1988 Aug; 24(4):415-22. PubMed ID: 2900656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TSH-response to TRH: A possible predictor of outcome to antidepressant and neuroleptic treatment.
    Langer G; Aschauer H; Koinig G; Resch F; Schönbeck G
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):335-42. PubMed ID: 6412314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of schizoaffective disorders.
    Goodnick PJ; Meltzer HY
    Schizophr Bull; 1984; 10(1):30-48. PubMed ID: 6142525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin response to thyrotropin-releasing hormone in RDC schizodepressed men.
    Wahby VS; Ibrahim GA; Giller EL; Mason JW; Saddik FW; Adams JR; Martin RP; Milad ER
    J Affect Disord; 1988; 15(1):81-5. PubMed ID: 2970496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test and thyroid stimulating hormone response to TRH in RDC schizoaffective patients.
    Sauer H; Koehler KG; Sass H; Hornstein C; Minne HW
    Eur Arch Psychiatry Neurol Sci; 1984; 234(4):264-7. PubMed ID: 6441714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to thyrotropin-releasing hormone in schizoaffective depressed compared to depressed and schizophrenic men and healthy controls.
    Wahby VS; Ibrahim GA; LeeChuy I; Saddik FW; Giller EL; Mason JW
    Schizophr Res; 1990; 3(5-6):277-81. PubMed ID: 2126454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients.
    van Kammen DP; Docherty JP; Marder SR; Bunney WE
    Psychiatry Res; 1981 Jun; 4(3):313-25. PubMed ID: 6115437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome study of first-episode psychosis. I: Relapse rates after 1 year.
    Rabiner CJ; Wegner JT; Kane JM
    Am J Psychiatry; 1986 Sep; 143(9):1155-8. PubMed ID: 2875663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin responses to thyrotropin-releasing hormone in alcohol-dependent patients with and without depression.
    O'Hanlon M; Barry S; Clare AW; Dinan TG
    J Affect Disord; 1991 Feb; 21(2):109-15. PubMed ID: 1827638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression.
    Krog-Meyer I; Kirkegaard C; Kijne B; Lumholtz B; Smith E; Lykke-Olesen L; Bjørum N
    Am J Psychiatry; 1984 Aug; 141(8):945-8. PubMed ID: 6431834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyrotropin response to thyrotropin-releasing hormone in endogenous depression.
    Kirkegaard C
    Psychoneuroendocrinology; 1981; 6(3):189-212. PubMed ID: 6794068
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in first-episode schizophrenia.
    Koreen AR; Siris SG; Chakos M; Alvir J; Mayerhoff D; Lieberman J
    Am J Psychiatry; 1993 Nov; 150(11):1643-8. PubMed ID: 8105706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant usage in schizophrenia.
    Plasky P
    Schizophr Bull; 1991; 17(4):649-57. PubMed ID: 1687176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin and prolactin responses to different doses of thyrotropin-releasing hormone in depression.
    Masturzo P; Tosca P; Murialdo G; Somenzini G; Cairoli S; Filippi U; De Palma D; Balbi D; Zerbi F
    Neuropsychobiology; 1989; 20(3):120-5. PubMed ID: 2503767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mania. Diagnosis, state measurement and prediction of treatment response.
    Secunda SK; Katz MM; Swann A; Koslow SH; Maas JW; Chuang S; Croughan J
    J Affect Disord; 1985; 8(2):113-21. PubMed ID: 3157719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.